[Clinical significance of des-gamma-carboxy prothrombin assay as a tumor marker].
作者信息
Yamano M
机构信息
Internal Medicine, Yamamoto Daisan Hospital.
出版信息
Nihon Rinsho. 1990 Feb;48 Suppl:999-1002.
PMID:1693989
Abstract
摘要
相似文献
1
[Clinical significance of des-gamma-carboxy prothrombin assay as a tumor marker].[去γ-羧基凝血酶原检测作为肿瘤标志物的临床意义]
Nihon Rinsho. 1990 Feb;48 Suppl:999-1002.
2
[Des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma].[肝细胞癌患者中的去γ-羧基凝血酶原]
Rinsho Byori. 1989 Feb;37(2):118-21.
3
[Clinical signification and evaluation of PIVKA-II in hepatocellular carcinoma].[异常凝血酶原在肝细胞癌中的临床意义及评估]
Rinsho Byori. 1989 Jun;37(6):683-6.
4
Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.使用血清去γ-羧基凝血酶原敏感检测法早期诊断肝细胞癌：一项前瞻性研究。
Hepatogastroenterology. 2002 Jan-Feb;49(43):235-8.
5
Performance characteristics of the LiBASys des-gamma-carboxy prothrombin assay.LiBASys去γ-羧基凝血酶原检测的性能特征
Clin Chim Acta. 2008 Mar;389(1-2):183-5. doi: 10.1016/j.cca.2007.11.031. Epub 2007 Dec 7.
6
[Early diagnosis of hepatocellular carcinoma by serum AFP and PIVKA-II analysis].[血清甲胎蛋白和异常凝血酶原分析用于肝细胞癌的早期诊断]
Nihon Naika Gakkai Zasshi. 1995 Dec 10;84(12):2003-7.
7
Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.同时测定甲胎蛋白和异常凝血酶原在监测肝细胞癌患者复发中的临床意义
Cancer. 1996 May 1;77(9):1781-6. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1781::AID-CNCR4>3.0.CO;2-F.
8
The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma.用于诊断肝细胞癌的去γ-羧基凝血酶原。
Ital J Gastroenterol. 1993 Jan;25(1):9-12.
9
[New clinical laboratory tests for digestive system diseases].[消化系统疾病的新临床实验室检测方法]
Nihon Naika Gakkai Zasshi. 2001 Nov 10;90(11):2213-8.
10
Zotero 插件